DR. ALAN DARE TONG, M.D.

Plain English
This study focused on a protein called PBK to see if it could help predict how likely pheochromocytomas and paragangliomas (two types of tumors) are to spread to other parts of the body. Researchers found that a higher percentage of PBK in tumor samples was linked to a greater chance of metastasis, with an odds ratio of 1.40, meaning those with higher PBK levels were more likely to have their cancer spread. This discovery is significant because it could improve how doctors assess cancer risk and guide treatment options for patients. Who this helps: This helps patients with pheochromocytomas and paragangliomas, as well as their doctors.

Plain English
Researchers studied a new drug called Q31 that targets a specific site on a protein (tubulin) involved in cancer cell growth. This drug was found to be very effective against ovarian cancer cells, with a strength measured at just 24.6 nanomoles per liter, and showed a significant ability to slow tumor growth by 74.12% in animal tests. This matters because it offers a promising new option for treating tumors that resist existing treatments. Who this helps: Patients with ovarian cancer.

Plain English
This study looked at how different imaging tests for prostate cancer—like MRI and PSMA-PET scans—can sometimes give conflicting results. The researchers found that these discrepancies can complicate treatment decisions for patients, affecting how doctors choose to manage care. By discussing these differences in a team setting, doctors can better determine the best approach for treating prostate cancer. Who this helps: This helps patients with prostate cancer and their doctors.

Plain English
This study developed a machine learning model, called ProMT-ML, to help determine which patients with suspected prostate cancer should receive MRI scans. The model showed that it can better identify cases needing further investigation than the traditional prostate-specific antigen (PSA) test; for example, Model A had an accuracy score of 0.711 compared to PSA's score of 0.593. This matters because it helps prioritize MRI tests for patients who are more likely to have serious issues, potentially speeding up diagnosis and treatment. Who this helps: This benefits patients suspected of having prostate cancer by ensuring they receive the right imaging tests based on their individual risk.

Plain English
Researchers studied a new treatment for glioblastoma, a deadly brain tumor, using an engineered virus called HSV-SUR15. They discovered that this virus not only grows better in tumor cells but also boosts the immune system's response by activating important immune cells. In tests with mice, HSV-SUR15 significantly slowed tumor growth and helped the immune system fight back against the cancer. Who this helps: This benefits glioblastoma patients by providing a potential new treatment option.

Plain English
This study examined how artificial intelligence (AI) can improve prostate MRI scans, which are important for detecting and assessing prostate cancer but are currently limited by high costs and inconsistent results. The research found that AI can help in several ways, including speeding up the scan process, improving image quality, and making interpretations as reliable as trained radiologists. AI technologies are becoming available that can enhance patient care by making prostate MRI safer and more widely accessible. Who this helps: This benefits patients with prostate cancer and healthcare providers managing their care.

Plain English
This study focused on how a plant hormone called auxin affects the production of nicotine in the Nicotiana plant species, which produce nicotine as a defense against insects. Researchers discovered that a protein named NaARF5 inhibits nicotine production by interfering with another protein, NaERF1-like; in plants with reduced NaARF5 function, nicotine levels increased significantly, while overexpressing NaARF5 greatly decreased nicotine levels. Understanding this mechanism is important because it offers new ways to control nicotine production, which could benefit breeding programs aimed at improving crop resilience and pest resistance. Who this helps: This helps farmers and plant breeders looking to enhance tobacco plants' resistance to pests.

Plain English
This study examined how nanotechnology can improve a type of cancer treatment called oncolytic virotherapy (OVT), which uses viruses to attack tumors. Researchers found that new techniques, like using nanoparticles to shield the viruses from the immune system and enhance their ability to target tumors, significantly boost their effectiveness. These advancements are crucial because they may enable better delivery of treatments and improve patient outcomes. Who this helps: This helps cancer patients looking for more effective treatment options.

Plain English
This study looked at a new method for interpreting unclear results from PSMA-PET scans in prostate cancer patients, specifically focusing on bone and lymph node lesions. Researchers developed a consensus algorithm that combined different types of imaging and patient information to better classify these unclear spots. By using this algorithm, they found that only 4.9% of cases were considered unclear, which is much less compared to previous methods that had up to 64.2% unclear cases. Who this helps: This approach benefits doctors and prostate cancer patients by providing clearer guidance for treatment decisions.

Plain English
This study looked at how a specific signaling pathway affected brain function after bleeding inside the brain, known as intraventricular hemorrhage (IVH), and its complications, notably post-hemorrhagic hydrocephalus (PHH). Researchers found that blocking the CCR2 pathway improved brain fluid circulation, reduced swelling in the brain's ventricles, and improved neurological function. Specifically, treatment led to better brain fluid clearance and reduced swelling, suggesting a potential new way to treat patients suffering from this condition. Who this helps: This helps patients recovering from brain hemorrhages and their families.

Plain English
This study focused on a new medication called finerenone for treating primary aldosteronism, a condition that causes high blood pressure. Researchers treated 57 adults with finerenone for 12 weeks and found that it significantly reduced daytime blood pressure by about 6.7 mmHg and office blood pressure by about 15.6 mmHg. Moreover, most patients had normal potassium levels after treatment, indicating that the drug is both effective and safe. Who this helps: This research benefits patients with primary aldosteronism who need effective treatment options for their high blood pressure.

Plain English
This study looked at advanced materials made from inorganic high-performance fibers (IHPFs) to help reduce problems caused by electromagnetic interference (EMI) in fields like industry and aerospace. Researchers found that while these fibers are lightweight and strong, they usually have issues sticking to other materials, which affects their durability. By using special techniques to improve their surfaces, they created stronger and more reliable composite materials that can better shield against EMI, ultimately helping to develop effective, long-lasting protection for sensitive equipment. Who this helps: This helps manufacturers and engineers working with electronic devices and military equipment.

Plain English
This study focused on creating a new sensor to quickly and accurately detect a specific type of genetic material called VEGF mRNA, which is important for diagnosing and treating diseases. The researchers developed a biosensor that can detect very low levels of VEGF mRNA (as small as 1.01 nanomolar), and also visualize it inside cells while reducing its expression, which may lead to new treatments for related diseases. This research is significant because it improves the way we monitor important biomarkers, which can ultimately enhance disease diagnosis and therapy options. Who this helps: This benefits patients by potentially leading to better disease management strategies.

Plain English
This study looked at a new treatment called YMN-V115, a special type of antibody designed to attack multiple myeloma, a form of blood cancer that often comes back after treatment. Researchers found that YMN-V115 worked much better than existing treatments, successfully targeting cancer cells even when cancer tries to hide from the immune system. Specifically, the antibody was effective even in challenging conditions, showing strong results in lab tests and animal studies. Who this helps: This helps patients with relapsed or refractory multiple myeloma by providing a promising new treatment option.

Plain English
This study explored a new treatment strategy for rheumatoid arthritis (RA) that combines two approaches: an oral therapy using special microspheres made from microalgae and ginseng, and an injection of a steroid to reduce joint inflammation. The researchers found that this combined therapy greatly improved joint function and reduced inflammation, showing significant immune system changes. Specifically, it led to an increase in beneficial immune cells and a healthier gut environment, contributing to better overall management of RA symptoms. Who this helps: This benefits patients with rheumatoid arthritis looking for more effective treatment options.

Plain English
The study focused on creating a new tool called SPECTRE, which uses advanced algorithms to help identify the chemical structures of natural products faster and more accurately using nuclear magnetic resonance (NMR) data. SPECTRE achieved a high accuracy of 80% in identifying molecules from a database of over 526,000 compounds and provides detailed visual maps that show how chemical fragments match up, even when the overall structure looks different. This is important because it speeds up the process of drug discovery, giving chemists better insights into potential new medicines. Who this helps: This helps researchers and chemists involved in drug development.

Plain English
This study looked at how a hormone produced by pancreatic beta cells, called cholecystokinin (CCK), affects the progression of pancreatic cancer linked to obesity. Researchers found that when mice became obese, CCK played a crucial role in promoting the development of tumors, more so than insulin, with a strong correlation between higher CCK levels and increased tumor growth. This is important because it identifies a specific signaling pathway that could be targeted to prevent or treat pancreatic cancer in obese individuals. Who this helps: Patients at risk of pancreatic cancer due to obesity.

Plain English
This study looked at a new treatment for wounds that don’t heal well in diabetics, which often become infected and inflamed. Researchers developed a special treatment using tiny nanoparticles that can kill bacteria and reduce inflammation. They found that this treatment could close wounds faster, showing over a 99% effectiveness against resistant bacteria in mice, which is important for improving healing in diabetic patients. Who this helps: Patients with diabetic wounds.

Plain English
This study looked at a new treatment approach for colorectal cancer that combines advanced technologies to boost the immune response against tumors. Researchers created a special type of nanobomb that combines metals and other components to improve the effectiveness of bispecific T-cell engagers, a type of therapy that prompts the body’s immune cells to fight cancer. The findings showed that this treatment could enhance T-cell activity, shrink tumors, and stop them from returning or spreading, making it a promising option for patients battling this disease. Who this helps: This benefits patients with colorectal cancer, especially those with advanced or recurrent stages of the disease.

Plain English
This paper examines the causes and recommended imaging methods for chronic pelvic pain in postmenopausal women, focusing on issues like pelvic inflammatory disease and cysts. It highlights that ultrasound is the first imaging test to use, while MRI or CT scans may be needed if the ultrasound results are unclear. These guidelines help doctors provide appropriate care based on the latest evidence, improving diagnosis and treatment for patients. Who this helps: This helps patients experiencing persistent pelvic pain.

Plain English
This study looked at a new way to display important patient information in intensive care units using a ring-based visual alarm system in a virtual reality setting. The researchers found that this new display allowed clinicians to respond to alarms 33% more accurately and 1 second faster than a traditional graph-based display. This matters because quicker and more accurate responses can improve patient care and safety in the ICU. Who this helps: This benefits ICU doctors and nurses by providing them with clearer information during critical situations.

Plain English
This study looked at a new method for predicting how things change over time from a starting point to multiple possible outcomes, which is important in various fields, including biology. The researchers developed a framework called BranchSBM that can better capture these complex transitions, allowing for simulations that show how cells might develop differently from a common starting point. They found that this method is more effective for tasks involving multiple potential outcomes, making it essential for understanding complex biological processes. Who this helps: This helps researchers and doctors studying cell development and treatment responses.

Plain English
This study looked at a type of rare tumors called pheochromocytomas and paragangliomas to see how a specific genetic score (HRD score) relates to the severity and spread of these tumors. Researchers analyzed data from 133 patients and found that a higher HRD score (above 7) is linked to worse outcomes, including a 33% higher risk of shorter survival without metastasis. Additionally, the HRD score increased in tumors treated with temozolomide, suggesting combining this treatment with other therapies could be beneficial. Who this helps: This research helps patients with pheochromocytomas and paragangliomas by improving risk assessment and treatment options.

Plain English
This study looked at a rare genetic condition called complete 17-alpha-hydroxylase deficiency (17-OHD) in 113 patients from 107 families in China. Researchers identified 50 harmful genetic changes related to this condition, including six new ones, and found that nearly all patients exhibited some common symptoms like high blood pressure (93.58%) and low potassium levels (74.31%). Understanding these genetic variants is important because it aids in diagnosis and helps tailor treatment strategies for affected individuals. Who this helps: This research benefits patients with 17-OHD and their doctors.

Plain English
This research focused on a new treatment for ovarian cancer that targets a specific protein called Claudin-6, which is often found in higher amounts in cancer cells but not in normal tissues. The study found that a new type of therapy called a bispecific T-cell engager, made using a novel delivery method, successfully activated immune cells to attack cancer cells without causing significant side effects. This is important because it offers a promising new way to fight ovarian cancer, potentially leading to better outcomes for patients facing this aggressive disease. Who this helps: Patients with ovarian cancer.

Plain English
This study looked at how Shengqing Jiangzhuo (SQJZ) Capsules could help treat chronic kidney failure in rats by affecting gut bacteria and body chemistry. The researchers found that rats with kidney failure showed higher levels of harmful substances and inflammation markers, but those that received SQJZ treatment had significantly improved kidney function, with reductions in these markers and reduced kidney damage. Overall, SQJZ Capsules helped restore kidney health and normalized gut bacteria, which could be an important approach for treating chronic kidney failure. Who this helps: This helps patients with chronic kidney failure.

Plain English
This study looked at how genetic risks for ADHD affect brain activity related to cognitive control, which is the ability to focus and make decisions. Researchers found that people with higher genetic risk for ADHD showed more variability in brain activity during tasks that require cognitive control, accounting for about 2.5% of the differences seen. This is important because it helps us understand the biological basis of ADHD and could lead to better interventions for managing these challenges. Who this helps: This research benefits patients with ADHD and their doctors by providing insights into the condition's genetic and neurological underpinnings.

Plain English
This study focused on a new type of cancer vaccine designed to combat liver cancer by enhancing the immune response. The researchers created a vaccine using modified liver cancer cells that expressed a substance called GM-CSF, which led to strong protection against tumors. They found that this vaccine not only stimulated important immune cells but also improved the immune system's ability to attack cancer over time, which is a significant step considering liver cancer is a major cause of cancer deaths. Who this helps: This helps patients with liver cancer by potentially providing a more effective treatment option.

Plain English
This study looked at a new treatment for rheumatoid arthritis (RA) using a special form of spirulina, a type of seaweed, mixed into a gel that is taken by mouth. Researchers found that this gel helped restore the gut’s protective barrier and reduced joint inflammation in mice. It improved the condition by slowing down joint damage and enhancing the effectiveness of another RA drug, methotrexate. Who this helps: This research benefits patients with rheumatoid arthritis.

Plain English
This study looks at hydrogels, which are jelly-like materials made of lots of water, and how they can be improved to work better in tough conditions, like in medical implants or soft robotics. Researchers found ways to make these hydrogels not only stronger through various techniques, but also able to change their properties in response to things like heat or light. This is important because it means these advanced hydrogels can be used in smarter and more adaptable ways, potentially enhancing applications in healthcare and robotics. Who this helps: Patients, doctors, and engineers working in biomedical technology and robotics.

Plain English
Researchers studied a new type of nanoparticle designed to treat inflammatory bowel diseases (IBD) by targeting two key issues: cell death that promotes inflammation (called pyroptosis) and excessive amounts of cell-free DNA (cfDNA) that also contribute to inflammation. They found that these nanoparticles effectively reduced the problems associated with IBD in mice, showing they could lower inflammation and improve tissue health without harming cells. This matters because it offers a new way to treat IBD by simultaneously addressing two major causes of inflammation. Who this helps: Patients suffering from inflammatory bowel diseases.

Plain English
This study focused on developing a new treatment for patients suffering from advanced human papillomavirus (HPV)-related cancers, which currently have limited options. Researchers combined a therapeutic vaccine with an oncolytic virus (SKV-012) and found that this combination significantly slowed tumor growth in mice. Specifically, the treatment led to stronger immune responses that helped clear tumors, showing promise for improving outcomes in patients with HPV-related cancers. Who this helps: This research benefits patients with HPV-associated cancers by offering a potential new treatment option.

Plain English
This study focused on improving basalt fiber fabric (BFF) to make it better at blocking electromagnetic interference (EMI) and heat. The researchers developed a new process that enhanced the fabric’s performance, achieving an impressive EMI shielding effectiveness of 53.47 decibels. This advancement is important because it means the fabric can be used for better protection in industrial and military applications while also having potential for creating colorful designs. Who this helps: This helps manufacturers and designers in industries like aerospace and military.

Plain English
This study looked at how effective a type of radiation therapy, called stereotactic body radiotherapy (SBRT), is for treating prostate cancer by using a method called multiparametric MRI (mpMRI) to assess tumor response six months after treatment. Researchers followed 72 patients and found that 51.4% had no visible remaining cancer on the mpMRI after treatment. Those patients with a complete response also saw a significant drop in their prostate-specific antigen (PSA) levels, reducing by an average of 81.8% compared to 66.1% for those without a complete response, indicating better treatment outcomes. Who this helps: This helps prostate cancer patients and their doctors by providing clearer insights into treatment effectiveness and potential next steps.

Plain English
This study focused on improving treatment for colorectal cancer by creating a special delivery system called a nanozyme that combines two therapies: a STING activator and a cancer-fighting treatment known as bispecific T-cell engagers (BiTEs). The researchers found that this nanozyme effectively targeted tumors and improved immune response, leading to better outcomes in attacking cancer cells. Their approach showed promise in making treatments more effective, addressing issues of stability and toxicity that usually limit existing therapies. Who this helps: This benefits colorectal cancer patients seeking more effective treatment options.

Plain English
This study looked at how different nutrient mixtures affect the behavior and characteristics of retinal pigment epithelium (RPE) cells, which are important for eye health and are often used to research age-related macular degeneration (AMD). Researchers tested six different nutrient environments and found that certain combinations, like B27 supplement in X-VIVO 10, made the RPE cells larger and more efficient at performing their functions. These findings emphasize that the nutrients used when growing RPE cells can significantly change their properties, which is important for accurately modeling eye diseases. Who this helps: This helps researchers studying eye diseases and developing treatments for patients with AMD.

Plain English
This study looked at how black phosphorus nanosheets can help fight cancer by improving how cells produce energy and boosting the immune response. Researchers found that these nanosheets reduced cancer growth in melanoma cells and activated the immune system, leading to more CD8 T cells, which help attack tumors. The combination of black phosphorus with existing cancer drugs could be a promising approach to enhance treatment effectiveness. Who this helps: This benefits cancer patients, particularly those with melanoma.

Plain English
This study looked at how different types of messages influence people to share medical crowdfunding projects on social media. Researchers found that messages focusing on a person's urgent needs lead to more shares when given to small, targeted groups, while messages that highlight what others are doing (bandwagon appeals) encourage sharing when broadcasted to a larger audience. Understanding these differences helps improve how medical crowdfunding campaigns reach potential donors. Who this helps: This benefits patients relying on crowdfunding for medical expenses and their supporters.

Plain English
This study looked at how well two imaging techniques, MRI and PSMA PET/CT, can stage prostate cancer and help plan treatment for patients at risk. It found that MRI outperformed PSMA PET/CT in identifying cancer spread outside the prostate and in correctly assessing which side of the prostate the cancer is on. Specifically, MRI detected this spread 23.5% of the time compared to 7.8% for PSMA PET/CT, and was more accurate in pinpointing cancer location (86.7% vs. 56.7%). Who this helps: This information benefits doctors and patients dealing with intermediate-risk and high-risk prostate cancer, improving how they plan treatment.

Plain English
The study focused on using a specially engineered virus carried by immune cells called macrophages to treat glioma, a type of brain tumor. Researchers developed a virus that targets and destroys cancer cells while leaving healthy cells unharmed, resulting in longer survival for treated mice. Specifically, this approach showed significant tumor infiltration and improved treatment effectiveness, suggesting a new way to make viral therapies more successful in fighting glioma. Who this helps: This helps patients with glioma and their doctors seeking more effective treatment options.

Plain English
This study looked at the types of pancreatic problems (lesions) in 90 patients with von Hippel-Lindau disease, a genetic condition affecting multiple organs. They found that 61% of these patients had related pancreatic issues, including simple cysts (56.4%), neuroendocrine tumors (58.2%), and a few instances of serous cystadenoma. Notably, mutations in two specific spots of the VHL gene (codons 161 and 167) were more commonly linked to neuroendocrine tumors, which could help with better targeted treatments. Who this helps: This benefits patients with von Hippel-Lindau disease and their doctors.

Plain English
This study explored a new way to deliver a plant-based treatment for depression directly to the brain through the nose. Researchers created a special gel that carries tiny particles from Chlorella vulgaris, which they found helped reduce symptoms of depression and anxiety in mice more quickly and effectively than traditional antidepressants. The treatment also improved brain health by protecting against damage and promoting the growth of new brain cells. Who this helps: This helps patients with depression and anxiety, offering a potentially faster and safer treatment option.

Plain English
This study focused on a new method of targeting proteins using modified molecules called arylfluorosulfate (AFS) aptamers. Researchers found that these AFS aptamers could effectively and rapidly bind to specific proteins, like the HER3 receptor, within just one minute, significantly outpacing previous methods. This is important because it could lead to new and more effective treatments for diseases that involve these proteins, as the ability to block their interactions might help in reducing harmful cellular processes. Who this helps: This benefits patients needing targeted therapies for conditions like cancer.

Plain English
This study looked at how well and safely a drug called anlotinib works in patients with metastatic pheochromocytoma and paraganglioma, which are rare tumors. Of the 22 patients who could be evaluated, 95.5% experienced disease control, and 31.8% had a positive response to the treatment. The average time before the disease got worse (progression-free survival) was about 22.6 months, but many patients dealt with side effects, especially high blood pressure and thyroid issues. Who this helps: This information benefits patients with metastatic pheochromocytoma and paraganglioma, as well as their doctors in managing treatment options.

Plain English
This research focused on a new treatment called αBC-IL15, designed to boost the immune response against glioblastoma (GBM), a severe type of brain tumor. The study found that αBC-IL15 effectively activates immune cells and enhances their ability to kill tumor cells, both in lab tests and in living organisms, showing a promising improvement in anti-tumor effects. This matters because glioblastomas typically suppress the immune system, making treatments challenging, so a method that improves immune function could lead to better outcomes for patients. Who this helps: Patients with glioblastoma.

Plain English
This study looked at new treatments for multiple myeloma, a type of blood cancer that often comes back even after treatment. Researchers found that combining a special therapy targeting LILRB4 on cancer cells with cGAS-STING drugs significantly improved the ability of natural killer (NK) cells to kill cancer cells, showing strong results in lab models. Specifically, this combination spurred much stronger anti-cancer activity, making it a promising option for patients with hard-to-treat forms of multiple myeloma. Who this helps: This helps patients with relapsed or refractory multiple myeloma.

Plain English
In this study, researchers looked at a new treatment for retinoblastoma (a common eye cancer in children) by using a special gel to deliver two medicines: an oncolytic adenovirus that targets cancer cells and a chemotherapy drug called melphalan. They found that this combination, delivered using a gel, effectively controlled tumor growth without damaging the retina, preserving eye function. Specifically, mice treated with this method showed sustained delivery of the drugs and maintained healthy retinal structure, suggesting a promising approach for treating retinoblastoma with reduced side effects. Who this helps: This helps children with retinoblastoma and their families by potentially improving treatment outcomes while protecting their vision.

Plain English
Researchers developed a new treatment using a plant-based gel that includes silver nanoparticles to help heal difficult diabetic wounds infected with a resistant type of bacteria called MRSA. In lab tests, this gel killed 95.6% of the MRSA bacteria, and in tests on mice, it helped wounds shrink to just 5.4% of their original size within 11 days. This treatment is important because it can effectively reduce infections and speed up healing for people with diabetes who struggle with chronic wounds. Who this helps: Patients with diabetic wounds, especially those infected with MRSA.